Apr 07, 2020
Visiongain Report Analyses Leading Players Within the $41bn Vaccines Market
Mar 26, 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Jan 30, 2020
United States' $9 Billion Pneumonia Vaccine Industry, 2020-2026 - Major Players are Merck, Pfizer, GlaxoSmithKline (GSK), LG Chem, and SK Chemical (Sanofi Pasteur)
Jan 30, 2020
SutroVax Announces Executive Appointment
Jan 28, 2020
PNEUMOSIL®, the new pneumococcal vaccine, achieves WHO prequalification, a key step toward improving access and affordability
Dec 20, 2019
New pneumococcal vaccine from Serum Institute of India achieves WHO prequalification
Dec 17, 2019
Chinese Vaccine Market Outlook to 2025: Meningococcal Meningitis, Pneumococcal, and DTP Vaccine has a Significant Market Share in China
Nov 27, 2019
Global pneumococcal vaccines market is expected to grow with a CAGR of 3.3% over the forecast period from 2019-2025
Nov 07, 2019
China Human Vaccine Industry Report, 2019-2025 Featuring 22 Human Vaccine Companies
Nov 05, 2019
United States Vaccines Market to 2026: Detailed Analysis of the Leading 27 Vaccine Market Assessments
Sep 13, 2019
$10.5+ Billion Pneumococcal Vaccines Market - Global Forecasts from 2019 to 2024
Sep 03, 2019
SutroVax Receives CARB-X Award for Up to $15 Million to Develop a Universal Vaccine to Prevent Group A Streptococcus Infections
Jul 12, 2019
Pneumonia Vaccines Market to Reach $9.6 Billion by 2025 - Rise in Government Focus on Immunization Programs is a Key Driver
Jul 09, 2019
V114 Sales for Pneumococcal Vaccination across the US, Japan, and Five Major EU Markets, 2017-2026
Jun 18, 2019
Global Pneumococcal Vaccines Market and Forecast Analysis 2018-2022: V114 and GSK-3 will Threaten the Dominance of Prevnar 13 with Potential for Broader Coverage, Starting in 2022
Jun 17, 2019
Global Conjugate Vaccines Market to Surpass US$ 27,015.3 Million by 2026
Jun 10, 2019
Global Vaccines Market to 2025: Shingrix is Set to Achieve Blockbuster Vaccine Status / GSK Led the Market in 2018 / Prevnar/Prevnar 13 has Captured the Highest Market Share
Dec 07, 2018
Global Human Vaccines Strategic Business Report 2018: Analysis & Forecast 2016-2024 - Market Trends & Issues
Jul 24, 2018
Pneumococcal Vaccines Market is Projected to Register a CAGR of 9.1% Over the Forecast Period 2018 -2028
Jun 07, 2018
SutroVax Announces $85M Series C Financing led by TPG Growth